Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity

QR Code

Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity

None

Saved in:

Bibliographic Details
Main Authors:	Goukassian, David, Morgan, James, Yan, Xinhua
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/32611
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of ErbB Receptors in Endometrial Cancer
by: Georgios, Adonakis, et al.
Published: (2012)

Clinicopathological value of ErbB2 gene and protein expression in osteochondroma
by: Zhen Huang, et al.
Published: (2020-01-01)

Exploring the Effects of Acupuncture on Behaviors of Autism Spectrum Disorder Based on the NRG1/ErbB4 Signaling Pathway
by: ZHUANG Wanyu, et al.
Published: (2025-02-01)

Vitamin D ameliorates prediabetic cardiac injure via modulation of the ErbB4/ferroptosis signaling axis
by: Yufan Miao, et al.
Published: (2025-07-01)

Mapping of an epitope of ErbB-2 for recognizing by monoclonal antibody 4B8 using phage display technolog
by: M. B. Borgoyakova, et al.
Published: (2016-02-01)

ErbB2/HER2: Its Contribution to Basic Cancer Biology and the Development of Molecular Targeted Therapy
by: Yamamoto, Tadashi, et al.
Published: (2011)

Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update
by: Vasvi Bhutani, et al.
Published: (2025-05-01)

Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future
by: A. M. Chaulin, et al.
Published: (2022-03-01)

Non-Coding RNAs in the Regulation of Doxorubicin-Induced Cardiotoxicity
by: Mengyao Sun, et al.
Published: (2025-05-01)

Integrin-Mediated Endothelial Cell Adhesion and Activation of c-Src, EGFR and ErbB2 are Required for Endothelial-Mesenchymal Transition
by: Arciniegas, Enrique, et al.
Published: (2011)

Curcumin exerts protective effects against doxorubicin-induced cardiotoxicity
by: O. О. Klymenko, et al.
Published: (2025-02-01)

5-Oxoproline prevents doxorubicin-induced cardiotoxicity and tumor growth
by: Xinning Guo, et al.
Published: (2025-09-01)

Assessment of circulating biomarkers in a rat model of doxorubicin-induced cardiotoxicity
by: Emilia ANCA, et al.
Published: (2024-12-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

Synthetic antioxidant TS-13 reduces doxorubicin cardiotoxicity
by: E. B. Menshchikova, et al.
Published: (2023-10-01)

Plasma Level’s of Neuregulin-1 in Healthy People
by: K. A. Zhbanov, et al.
Published: (2022-01-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Tetrahedral Framework Nucleic Acids Inhibit Oxidative Stress and Cardiomyocyte Apoptosis in Doxorubicin-Induced Cardiotoxicity
by: Pan H, et al.
Published: (2025-07-01)

Mechanistic Insights into Flavonoid Subclasses as Cardioprotective Agents Against Doxorubicin-Induced Cardiotoxicity: A Comprehensive Review
by: Shang W, et al.
Published: (2025-07-01)

From obscurity to opportunity: targeting Neuregulin 1 fusions in solid tumors
by: Sofía Llorente, et al.
Published: (2025-06-01)

Investigating the impact of ALDH2 on doxorubicin-induced cardiotoxicity using ALDH2*2 knock-in mice through proteomics analysis
by: Yi Ye, et al.
Published: (2025-06-01)

Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
by: K. A. Zhbanov, et al.
Published: (2022-11-01)

Reduced plasma levels of neuregulin-1 are associated with adverse outcomes in patients with atherosclerotic cardiovascular disease
by: Jie Liu, et al.
Published: (2025-07-01)

The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
by: D. A. Andreev, et al.
Published: (2024-03-01)

Leveraging a Multi-Omics Approach to Reveal the Cardioprotective Effect of Losmapimod against Doxorubicin-Induced Cardiotoxicity in C57BL/6 Mice
by: Mohamed Dabour, et al.
Published: (2025-06-01)

Seelsorge als Denkdiakonie. Reformatorisches Erbe in der heutigen Seelsorge
by: Dávid NÉMETH
Published: (2017-12-01)

Serum levels of neuregulin-1 in patients with coronary artery disease: clinical and pathogenetic aspects
by: E. A. Zakharyan, et al.
Published: (2024-02-01)

Nuclear imaging of chemotherapy-induced cardiotoxicity
by: A. A. Ansheles, et al.
Published: (2021-03-01)

ADMET-AI enables interpretable predictions of drug-induced cardiotoxicity
by: Kyle Swanson, et al.
Published: (2025-06-01)

Caffeic Acid Phenethyl Ester Protects Against Doxorubicin-Induced Cardiotoxicity via Inhibiting the ROS-MLKL-Mediated Cross-Talk Between Oxidative Stress and Necroptosis
by: Chenying Jiang, et al.
Published: (2025-05-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

Correction: Bhutani et al. Doxorubicin-Induced Cardiotoxicity: A Comprehensive Update. <i>J. Cardiovasc. Dev. Dis.</i> 2025, <i>12</i>, 207
by: Vasvi Bhutani, et al.
Published: (2025-06-01)

Photobiomodulation Therapy Reduces Oxidative Stress and Inflammation to Alleviate the Cardiotoxic Effects of Doxorubicin in Human Stem Cell-Derived Ventricular Cardiomyocytes
by: Guilherme Rabelo Nasuk, et al.
Published: (2025-07-01)

ROLE OF NEUREGULINS AND HEPATOCYTE GROWTH FACTOR IN THE DEVELOPMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: L. V. Spirina, et al.
Published: (2016-02-01)

Promising Mesenchymal Stem Cell Intervention for Relieving Cardiac Recovery against Cardiotoxic Injury Modeling with Doxorubicin: A Novel Therapeutic Approach
by: Ozgermen Deva Basak Boztok, et al.
Published: (2025-06-01)

Trastuzumab and Cardiotoxicity
by: Fiuza, M., et al.
Published: (2012)

Anthracycline Cardiotoxicity
by: Visani, Giuseppe, et al.
Published: (2012)

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
by: I. T. Murkamilov, et al.
Published: (2021-03-01)

Natural strategies of preventing anthracycline-induced cardiotoxicity – a review
by: Anca STOICA, et al.
Published: (2022-12-01)